Veracyte, Inc.

About Veracyte, Inc.

Veracyte, Inc. is a genomic diagnostics company that develops and commercializes molecular tests to improve patient care in oncology and inflammatory diseases. Its tests analyze gene expression and other genomic information from patient samples to provide physicians with actionable insights for diagnosis, prognosis, and treatment selection. The company’s portfolio includes tests for thyroid, lung, breast, prostate, and bladder cancers, as well as idiopathic pulmonary fibrosis. Veracyte operates a CLIA-certified laboratory in South San Francisco and markets its products globally to healthcare providers and biopharmaceutical companies.